Renal cell carcinoma of variant histology: biology and therapies
P Msaouel, G Genovese… - Hematology/Oncology …, 2023 - hemonc.theclinics.com
Renal cell carcinomas (RCCs) are divided into distinct subtypes characterized by specific
molecular alterations. 1 Clear cell renal cell carcinoma (ccRCC) constitutes w75% a …
molecular alterations. 1 Clear cell renal cell carcinoma (ccRCC) constitutes w75% a …
The Role of 99mTc‐Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic …
Context The diagnostic accuracy of current imaging techniques in differentiating benign from
malignant neoplasms in the case of indeterminate renal masses is still suboptimal. Objective …
malignant neoplasms in the case of indeterminate renal masses is still suboptimal. Objective …
Prediction of World Health Organization/International Society of Urological Pathology (WHO/ISUP) pathological grading of clear cell renal cell carcinoma by dual-layer …
X Zhang, G Zhang, L Xu, X Bai, J Zhang, L Chen… - Academic …, 2023 - Elsevier
Rationale and Objectives To evaluate whether the dual-layer spectral computed tomography
urography (DL-CTU) images could predict WHO/ISUP pathological grading of clear cell …
urography (DL-CTU) images could predict WHO/ISUP pathological grading of clear cell …
Pathological and clinical outcomes in a large surveillance and intervention cohort of radiographically cystic renal masses
RA Lee, RG Uzzo, J Anaokar, A Thomas… - The Journal of …, 2023 - auajournals.org
Purpose: We evaluated oncologic risks in a large cohort of patients with radiographic cystic
renal masses who underwent active surveillance or intervention. Materials and Methods: A …
renal masses who underwent active surveillance or intervention. Materials and Methods: A …
von-Hippel Lindau and hypoxia-inducible factor at the center of renal cell carcinoma biology
NH Shirole, WG Kaelin - Hematology/Oncology Clinics, 2023 - hemonc.theclinics.com
Kidney cancer is one of the 10 most common cancers in the developed world and is
increasing in incidence. In 2020 there were more than 400,000 new cases of kidney cancer …
increasing in incidence. In 2020 there were more than 400,000 new cases of kidney cancer …
Roles of MT-ND1 in Cancer
Y Xu, J Su, J Zhou, Q Yuan, J Han - Current Medical Science, 2023 - Springer
The energy shift toward glycolysis is one of the hallmarks of cancer. Complex I is a vital
enzyme complex necessary for oxidative phosphorylation. The mitochondrially encoded …
enzyme complex necessary for oxidative phosphorylation. The mitochondrially encoded …
[HTML][HTML] An update on the treatment of papillary renal cell carcinoma
Simple Summary Papillary renal cell carcinoma is the second most common type of kidney
cancer, after clear cell kidney cancer. Given that it is relatively rare, studying this disease has …
cancer, after clear cell kidney cancer. Given that it is relatively rare, studying this disease has …
[HTML][HTML] 2023 UPDATE–Canadian Urological Association guideline: Management of cystic renal lesions: Prior to original publication (March 2017), this guideline …
PO Richard, PD Violette, B Bhindi… - Canadian Urological …, 2023 - ncbi.nlm.nih.gov
METHODS A comprehensive search of the literature was carried out on June 30, 2016, in
MEDLINE and PubMed, which identified 77 relevant studies to inform the development of …
MEDLINE and PubMed, which identified 77 relevant studies to inform the development of …
[HTML][HTML] The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell …
L Zhang, L Di, J Liu, X Lei, M Gu, W Zhang… - Frontiers in …, 2023 - frontiersin.org
Cuproptosis is a new form of cell death, the second form of metal ion-induced cell death
defined after ferroptosis. Recently, cuproptosis has been suggested to be associated with …
defined after ferroptosis. Recently, cuproptosis has been suggested to be associated with …
[HTML][HTML] Renal cell carcinoma in end-stage renal disease: A retrospective study in patients from Hungary
D Semjén, B Dénes, Á Somorácz, A Fintha, G Forika… - Pathobiology, 2023 - karger.com
Introduction: End-stage renal disease (ESRD) and acquired cystic kidney disease (ACKD)
are known risk factors for renal cell carcinoma (RCC). Hereby, the clinicopathological …
are known risk factors for renal cell carcinoma (RCC). Hereby, the clinicopathological …